MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Monday, October 8, 2018

1:15pm-2:45pm
Usefulness of a simple symptom assessment scale for multiple system atrophy: data from HoRC-MSA Project

M. Matsushima, K. Sakushima, I. Yabe, Y. Kanatani, Y. Ito, T. Matsuoka, T. Katayama, H. Uesugi, K. Sako, A. Takei, S. Shimohama, N. Sato, S. Kikuchi, H. Sasaki (Sapporo, Japan)

Rating Scales  ·  Hall 3FG
1:15pm-2:45pm
Using Vision to Predict Dementia in Parkinson’s Disease

L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

Parkinson's Disease: Cognition  ·  Hall 3FG
1:15pm-2:45pm
Utilizing latent class analysis to explore the sleep disturbance subtypes in Parkinson’s disease patients

H.J. Yang, H.J. Kim, S.J. Kim (Ulsan, Republic of Korea)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Validation of a One-Page Impulse Control Disorder Questionnaire in a Parkinson’s Disease Clinic

L. Williams, B. Magennis, N. Feerick, T. Lynch (Dublin, Ireland)

Parkinson's Disease: Psychiatric Manifestations  ·  Hall 3FG
1:15pm-2:45pm
Validation of a patient/caregiver questionnaire to evaluate nocturnal hypokinesia in Parkinson’s disease

R. Bhidayasiri, O. Jitkritsadakul, J. Sringean, P. Martinez-Martin, C. Anan, N. Kantachadvanich, R. Chaudhuri, N. Hattori (Bangkok, Thailand)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Validation of protein phosphatases that regulate the LRRK2 phosphorylation cycle

M. Drouyer, M. Emanuele, R. Lefebvre, K. Cailliau-Maggio, A. martoriati, T. Comptdaer, P. Semaille, E. Mutez, W. Sibran, N. Wolkoff, E. Lobbestael, M. Bolliger, V. Baekelandt, J. Nichols, MC. Chartier-Harlin, JM. Taymans (Lille, France)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG
1:15pm-2:45pm
Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)

V. Luk, N. Cheung, G. Chan, KF. Leung, NFJ. Lui, WW. Wong, I. Chan, C. Li (Kowloon, Hong Kong)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG
1:15pm-2:45pm
Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report

D. Ciampi-de-Andrade, S. Perez-Lloret, N. Hollenstein, R. Curry, V. Rossetto Barbosa, G. Kägi, S. Hägele-Link, J. Walch, R. Gonzenbach, J-P. Lefaucheur, S. Beer, C. Möller, V. Mylius (Sao Paulo, Brazil)

Rating Scales  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley